NCT01348880View on ClinicalTrials.gov

Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Erectile Dysfunction

Interventions

DRUG

Vardenafil ODT, (Staxyn, BAY38-9456)

Single dose of 10 mg of vardenafil ODT, taken without water

DRUG

Placebo

Single dose of placebo to match 10 mg vardenafil ODT. taken without water

Trial Locations (2)

33014

Miami

37920

Knoxville

Sponsors

Lead Sponsor

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Bayer

INDUSTRY